Who owns Supernus, Inc. (INDV)? Elite investor 13F holders

5 tracked elite investors reported holding Supernus, Inc as of 2026-09-30, including Oaktree Capital Management, Rubric Capital, D.E. Shaw, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Oaktree Capital ManagementINDIVIOR PHARMACEUTICALS INCSHARE2026-06-302026-08-14 00:00:00251399508.00 USD6127212.000000SharesbuyOriginal filing
Rubric CapitalINDIVIOR PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:00138488156.00 USD3862989.000000SharesbuyOriginal filing
D.E. ShawINDIVIOR PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:001299634.00 USD36252.000000SharesreduceOriginal filing
Gotham Asset ManagementINDIVIOR PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:003268194.00 USD91163.000000SharesreduceOriginal filing
Bridgewater AssociatesINDIVIOR PHARMACEUTICALS INCSHARE2026-09-302026-11-16 00:00:001241163.00 USD34621.000000SharesreduceOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown